# Sub-Q Bionics Pre-Seed Backed by Mayo Clinic Targets Bionic Lymph Node Implant

> financing · REPORTED · 2026-03-31

Sub-Q Bionics raised $1.5 million in pre-seed funding co-led by Mayo Clinic and Yeda of the Weizmann Institute, with Israel Innovation Authority matching funds, to advance its implantable bionic lymph node for lymphedema. Mayo Clinic will collaborate with the company on R&D as part of the deal.

About Sub-Q Bionics: Sub-Q Bionics is a medical device startup developing a subcutaneous implantable system that mimics lymph node function to automatically drain lymphatic fluid in cancer survivors and other patients suffering from lymphedema, a chronic swelling condition with limited current treatment options.

- Company: Sub-Q Bionics
- Sector: medical devices
- Primary source: https://finance.yahoo.com/sectors/healthcare/articles/sub-q-bionics-closes-1-132600151.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.